| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/14/2010 | WO2009140569A3 Genetic markers for weight management and methods of use thereof |
| 01/14/2010 | WO2009134409A3 Neural regenerating cells with alterations in dna methylation |
| 01/14/2010 | WO2009124312A3 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same |
| 01/14/2010 | WO2009124255A3 Methods for transcript analysis |
| 01/14/2010 | WO2009108860A3 Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders |
| 01/14/2010 | WO2009108856A3 Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof |
| 01/14/2010 | WO2009105154A3 Diagnostic and prognostic methods for cancer |
| 01/14/2010 | WO2009099642A3 Proteomic analysis of active multiple sclerosis lesions |
| 01/14/2010 | WO2009099465A3 Methods of using mir-199a as a marker and sequences of mir-199a as a therapeutic for cancer |
| 01/14/2010 | WO2009082744A3 Prognosis and interference-mediated treatment of breast cancer |
| 01/14/2010 | WO2009058851A3 Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level |
| 01/14/2010 | WO2009052159A3 Methods for selecting active agents for cancer treatment |
| 01/14/2010 | WO2009025690A4 Improved e. coli plasmid dna production |
| 01/14/2010 | WO2009023048A3 Markers for metabolic syndrome |
| 01/14/2010 | WO2008139259A9 Fluorescent proteins for monitoring intracellular superoxide production |
| 01/14/2010 | WO2008114000A8 Methods of producing haploid and doubled haploid oil palms |
| 01/14/2010 | WO2008086094A3 Microarray-based lineage analysis as a diagnostic for current and emerging strains of influenza b |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | WO2005097421A9 Methods for identifying risk of osteoarthritis and treatments thereof |
| 01/14/2010 | WO2005072050A9 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | WO2003012125A9 Mre11: modulation of cellular proliferation |
| 01/14/2010 | WO2002090904A9 Uv sensitive bacillus subtilis spores and biodosimetry applications |
| 01/14/2010 | US20100011461 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 01/14/2010 | US20100011458 Sweet pepper line sbr28-1220 |
| 01/14/2010 | US20100011457 Sweet pepper line sbr28-1244 |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100011451 Phenotypic and genotypic differences of mva strains |
| 01/14/2010 | US20100010749 Sequencing |
| 01/14/2010 | US20100010748 Method and system for DNA analysis |
| 01/14/2010 | US20100010630 Plastic implant impregnated with a degradation protector |
| 01/14/2010 | US20100010208 Purification of a triple helix formation with an immobilized oligonucleotide |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010084 High penetration prodrug compositions of retinoids and retinoid-related compounds |
| 01/14/2010 | US20100010073 Microrna (mirna) for the diagnosis and treatment of heart diseases |
| 01/14/2010 | US20100010056 Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists |
| 01/14/2010 | US20100010036 Drugs for the treatment of sarcoglycanopathies |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009938 Method to identify and treat subjects resistant to acetyl salicylic acid |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009905 Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer |
| 01/14/2010 | US20100009864 Method for analysing amplified nucleic acids |
| 01/14/2010 | US20100009863 Method for engineering t-cell receptors |
| 01/14/2010 | US20100009861 Breast cancer prognostics |
| 01/14/2010 | US20100009857 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/14/2010 | US20100009856 Randomized dna libraries and double-stranded rna libraries, use and method of production thereof |
| 01/14/2010 | US20100009461 Npcil1 (Npc3) And Methods Of Identifying Ligands Thereof |
| 01/14/2010 | US20100009436 High throughput assays for transmissible spongiform encephalopathies (TSE) |
| 01/14/2010 | US20100009432 Conductive carbon nanotubes dotted with metal and method for fabricating a biosensor using the same |
| 01/14/2010 | US20100009402 Method of evaluating breast cancer, breast cancer-evaluating apparatus, breast cancer-evaluating method, breast cancer-evaluating system, breast cancer-evaluating program and recording medium |
| 01/14/2010 | US20100009400 Methods of studying a biomarker, and methods of detecting a biomarker |
| 01/14/2010 | US20100009399 Novel population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells |
| 01/14/2010 | US20100009398 Biological reaction apparatus with draining mechanism |
| 01/14/2010 | US20100009397 Substrate-mimetic akt inhibitor |
| 01/14/2010 | US20100009396 Method for measuring the concentration of activated factor vii (fviia) in a sample |
| 01/14/2010 | US20100009395 Luminescence assay utilizing a genetically modified cell line |
| 01/14/2010 | US20100009383 Method for the simple and rapid detection of cells and biomolecules by means of paramagnetic particles |
| 01/14/2010 | US20100009382 Methods and compositions for diagnosing lung cancer |
| 01/14/2010 | US20100009381 Compositions and methods for detection and isolation of phosphorylated molecules |
| 01/14/2010 | US20100009378 determining levels of glycated CD59 in subjects; permit a rapid and reliable measure; highly accurate and reproducible; diabetes |
| 01/14/2010 | US20100009377 Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases |
| 01/14/2010 | US20100009376 Method for measuring dna methylation |
| 01/14/2010 | US20100009375 Silica Magnetic Particles with a High Nucleic Acid Binding Capacity |
| 01/14/2010 | US20100009374 Sire early selection for male fertility using single nucleotide polymorphisms (snps) of the dazl gene |
| 01/14/2010 | US20100009373 Methods and compositions relating to multiplex genomic gain and loss assays |
| 01/14/2010 | US20100009372 Determining ratio between preferentially amplified nucleotide sequences and standard at end point of polymerase chain reaction event |
| 01/14/2010 | US20100009371 Selection of markers |
| 01/14/2010 | US20100009370 Gene assaying method, gene assaying program, and gene assaying device |
| 01/14/2010 | US20100009369 Gene expression level analyzing method, gene expression level analyzing program, and gene expression level analyzing device |
| 01/14/2010 | US20100009368 Methods and compositions for the assessment of cardiovascular function and disorders |
| 01/14/2010 | US20100009367 Micro rnas and their methods of use for the treatment and diagnosis of schizophrenia and schizophrenia spectrum disorders |
| 01/14/2010 | US20100009366 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 01/14/2010 | US20100009365 Process for high-throughput dna methylation analysis |
| 01/14/2010 | US20100009364 Methods for diagnosis, prognosis and methods of treatment |
| 01/14/2010 | US20100009363 RBP4 In Insulin sensitivity/resistance, diabetes, and obesity |
| 01/14/2010 | US20100009362 Fluorescent water-soluable conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same |
| 01/14/2010 | US20100009361 Compositions and methods for detecting noonan syndrome |
| 01/14/2010 | US20100009360 Method for the detection of egfr mutations in blood samples |
| 01/14/2010 | US20100009359 Methods and compositions for detecting colon cancers |
| 01/14/2010 | US20100009358 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 01/14/2010 | US20100009357 Prediction of lung cancer tumor recurrence |
| 01/14/2010 | US20100009356 Diagnosis of cardiovascular disease |
| 01/14/2010 | US20100009355 Selective amplification of minority mutations using primer blocking high-affinity oligonucleotides |
| 01/14/2010 | US20100009354 Method for determining base sequence of dna |
| 01/14/2010 | US20100009353 Dye Compounds and the Use of their Labelled Conjugates |
| 01/14/2010 | US20100009352 Method for Modeling a Disease |
| 01/14/2010 | US20100009351 Polynucleotide Capture Materials, and Method of Using Same |
| 01/14/2010 | US20100009350 Method for quantitative analysis of transcripts with nucleotide polymorphism at specific site |
| 01/14/2010 | US20100009349 Method for Treating a Biological Sample |
| 01/14/2010 | US20100009348 Methods and Constructs for Analyzing Biological Activities of Biological Specimens and Determining States of Organism |
| 01/14/2010 | US20100009347 Kit and method for detecting urothelial cancer |
| 01/14/2010 | US20100009346 Lafora's disease gene |
| 01/14/2010 | US20100009345 Compositions and methods comprising a ligand of chemerin R |
| 01/14/2010 | US20100009344 Liquid crystal based analyte detection |
| 01/14/2010 | US20100009343 Compositions and method for rapid, real-time detection of influenza a virus (h1n1) swine 2009 |
| 01/14/2010 | US20100009342 Control of chemical modification |
| 01/14/2010 | US20100009341 Methods and means for assessing hiv gag/protease inhibitor therapy |